法学硕士支持的非洲初级卫生保健临床决策试验

IF 58.7 1区 医学 Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY
Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles
{"title":"法学硕士支持的非洲初级卫生保健临床决策试验","authors":"Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles","doi":"10.1038/s41591-025-03815-3","DOIUrl":null,"url":null,"abstract":"<p>Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity<sup>1</sup> and variable quality-of-care delivery<sup>2</sup>. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level<sup>3</sup> and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians<sup>4</sup>. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent<sup>5</sup>.</p><p>In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics<sup>6</sup>, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.</p>","PeriodicalId":19037,"journal":{"name":"Nature Medicine","volume":"76 1","pages":""},"PeriodicalIF":58.7000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Trials for LLM-supported clinical decisions in African primary healthcare\",\"authors\":\"Bilal A. Mateen, Vaishnavi Menon, Ambrose Agweyu, Robert Korom, Elizabeth Omoluabi, David McAfee, Natnael Shimelash, Samuel Rutunda, Crystal Rugege, Gwydion Williams, Mira Emmanuel-Fabula, Alastair K. Denniston, Xiaoxuan Liu, Melissa Miles\",\"doi\":\"10.1038/s41591-025-03815-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity<sup>1</sup> and variable quality-of-care delivery<sup>2</sup>. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level<sup>3</sup> and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians<sup>4</sup>. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent<sup>5</sup>.</p><p>In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics<sup>6</sup>, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.</p>\",\"PeriodicalId\":19037,\"journal\":{\"name\":\"Nature Medicine\",\"volume\":\"76 1\",\"pages\":\"\"},\"PeriodicalIF\":58.7000,\"publicationDate\":\"2025-07-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41591-025-03815-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41591-025-03815-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

撒哈拉以南非洲的初级卫生保健系统面临着相当大的挑战,特别是临床能力有限和提供的保健质量参差不齐。大型语言模型(llm)代表了临床决策的潜在变革解决方案。一些法学硕士已经表明,他们可以回忆专家级的临床知识,并且可以比临床医生更准确地诊断临床小插曲(在模拟环境中)。然而,尽管法学硕士已经显示出前景,但在非洲临床环境中安全有效地使用法学硕士的现实证据明显缺乏。到目前为止,在非洲大陆上只进行了少量的人工智能(AI)用于健康的随机试验(而没有进行人工智能生成工具的随机试验)。在肯尼亚,一项实用的随机对照试验(RCT)被纳入了16家Penda Health诊所的日常护理服务中。Penda Health是一家总部位于内罗毕的社会企业,为所有社会经济群体提供初级保健服务,从国家社会保险受益人到私人保险和自掏腰包的人。该试验的目标是招募9000名患者。正在试验的解决方案是一个基于法学硕士的“副驾驶”功能,该功能已直接集成到Penda的电子病历系统中。随机分配到干预组的临床医生在患者会诊期间收到自动、实时的诊断、治疗计划和实验室解释建议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Trials for LLM-supported clinical decisions in African primary healthcare

Trials for LLM-supported clinical decisions in African primary healthcare

Primary healthcare systems in sub-Saharan Africa face considerable challenges, particularly constrained clinical capacity1 and variable quality-of-care delivery2. Large language models (LLMs) represent a potentially transformative solution for clinical decision-making. Some LLMs have shown that they can recall clinical knowledge at expert level3 and can diagnose clinical vignettes (in simulated settings) more accurately than clinicians4. However, despite the fact that LLMs have shown promise, there is a striking lack of real-world evidence for their safe and effective use in clinical settings in Africa. Thus far, only handful of randomized trials of artificial intelligence (AI) for health (and none for generative AI tools) have been conducted on the continent5.

In Kenya, a pragmatic randomized controlled trial (RCT) has been embedded into routine care delivery undertaken at 16 of Penda Health’s clinics6, a Nairobi-based social enterprise that provides primary care services across all socioeconomic groups, from state social insurance recipients to privately insured and out-of-pocket payers. The trial aims to enroll 9,000 patients. The solution being trialed is an LLM-based ‘co-pilot’ feature that has been integrated directly into Penda’s electronic medical record system. Clinicians randomly assigned to the intervention arm receive automated, real-time suggestions for diagnosis, treatment planning and lab interpretation during patient consultations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nature Medicine
Nature Medicine 医学-生化与分子生物学
CiteScore
100.90
自引率
0.70%
发文量
525
审稿时长
1 months
期刊介绍: Nature Medicine is a monthly journal publishing original peer-reviewed research in all areas of medicine. The publication focuses on originality, timeliness, interdisciplinary interest, and the impact on improving human health. In addition to research articles, Nature Medicine also publishes commissioned content such as News, Reviews, and Perspectives. This content aims to provide context for the latest advances in translational and clinical research, reaching a wide audience of M.D. and Ph.D. readers. All editorial decisions for the journal are made by a team of full-time professional editors. Nature Medicine consider all types of clinical research, including: -Case-reports and small case series -Clinical trials, whether phase 1, 2, 3 or 4 -Observational studies -Meta-analyses -Biomarker studies -Public and global health studies Nature Medicine is also committed to facilitating communication between translational and clinical researchers. As such, we consider “hybrid” studies with preclinical and translational findings reported alongside data from clinical studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信